Literature DB >> 30792764

Safety and feasibility of above cuff vocalisation for ventilator-dependant patients with tracheostomies.

Brendan A McGrath1, Sarah Wallace2, Mark Wilson2, Leanne Nicholson2, Tim Felton1, Christine Bowyer1, Andrew M Bentley1.   

Abstract

INTRODUCTION: Temporary tracheostomy is commonly used in patients admitted to intensive care units. Cuffed tubes prevent laryngeal airflow, preventing vocalisation. Sub-glottic suction tubes such as the 'Blue Line Ultra Suctionaid™' are used primarily to remove sub-glottic secretions, but retrograde gas flows via the suction port can facilitate above cuff vocalisation. The aims were to assess whether patients could achieve an audible voice using above cuff vocalisation, to demonstrate the safe use of the Blue Line Ultra Suctionaid™ tracheostomy tube for above cuff vocalisation, and to assess potential benefits of above cuff vocalisation for communication, secretion management and swallowing.
METHODS: Our study (Reference 15/NW/0464, IRAS 178997) recruited adult intensive care unit patients who were alert, able to participate in an above cuff vocalisation trial and dependent on an inflated Blue Line Ultra Suctionaid™ cuff for ventilatory support. Consenting participants underwent fibreoptic endoscopic assessment of swallow by experienced Speech & Language Therapy staff with and without above cuff vocalisation. Clinical and fibreoptic endoscopic assessment of swallow, assessment of voice quality, swallowing and secretion management were recorded and scored. Median differences between paired observations and scores were analysed with and without above cuff vocalisation. Adverse events were identified by follow up fibreoptic endoscopic assessment of swallow and patient accounts.
RESULTS: Ten patients completed the study. Above cuff vocalisation was used for a median of 15 min, during a median of nine episodes, over a median of three days. Above cuff vocalisation resulted in an audible voice in eight of the 10 patients, during 66 out of 91 above cuff vocalisation attempts. There improvements in unstimulated dry cough and swallow frequency and aspiration ratings measured by fibreoptic endoscopic assessment of swallow. No complications were reported or observed in 66 attempts with only one episode terminated prematurely.
CONCLUSIONS: Above cuff vocalisation can achieve effective, safe, well-tolerated vocalisation in ventilator-dependant intensive care unit patients. Above cuff vocalisation has the potential to aid earlier, more effective communication and may improve laryngeal function and rehabilitation.

Entities:  

Keywords:  Tracheostomy; fibreoptic endoscopic assessment of swallow; swallowing; ventilator-dependent; vocalisation

Year:  2018        PMID: 30792764      PMCID: PMC6376581          DOI: 10.1177/1751143718767055

Source DB:  PubMed          Journal:  J Intensive Care Soc        ISSN: 1751-1437


  28 in total

1.  Swallowing and sensation: evaluation of deglutition in the anesthetized larynx.

Authors:  Lucian Sulica; Amanda Hembree; Andrew Blitzer
Journal:  Ann Otol Rhinol Laryngol       Date:  2002-04       Impact factor: 1.547

2.  Speaking cuffed tracheostomy tube.

Authors:  P Safar; A Grenvik
Journal:  Crit Care Med       Date:  1975 Jan-Feb       Impact factor: 7.598

3.  The gift of speech … priceless.

Authors:  Jeannette Dee Hoit
Journal:  Respir Care       Date:  2010-12       Impact factor: 2.258

4.  Functional MRI of oropharyngeal air-pulse stimulation.

Authors:  P Sörös; E Lalone; R Smith; T Stevens; J Theurer; R S Menon; R E Martin
Journal:  Neuroscience       Date:  2008-03-19       Impact factor: 3.590

5.  Preliminary report of laryngeal phonation during mechanical ventilation via a new cuffed tracheostomy tube.

Authors:  Melda Kunduk; Kimberly Appel; Mehtap Tunc; Zekeriyya Alanoglu; Neslihan Alkis; Gursel Dursun; Ozan B Ozgursoy
Journal:  Respir Care       Date:  2010-12       Impact factor: 2.258

Review 6.  Facilitating speech in the patient with a tracheostomy.

Authors:  Dean R Hess
Journal:  Respir Care       Date:  2005-04       Impact factor: 2.258

7.  Indications, timing, and techniques of tracheostomy in 152 French ICUs.

Authors:  François Blot; Christian Melot
Journal:  Chest       Date:  2005-04       Impact factor: 9.410

8.  Communication boards in critical care: patients' views.

Authors:  Lance Patak; Anna Gawlinski; Ng Irene Fung; Lynn Doering; Jill Berg; Elizabeth A Henneman
Journal:  Appl Nurs Res       Date:  2006-11       Impact factor: 2.257

9.  Tracheostomy tube enabling speech during mechanical ventilation.

Authors:  Hiroaki Nomori
Journal:  Chest       Date:  2004-03       Impact factor: 9.410

10.  Intensive care unit tracheostomy: a snapshot of UK practice.

Authors:  Tonny Veenith; Sangeetha Ganeshamoorthy; Thomas Standley; Joseph Carter; Peter Young
Journal:  Int Arch Med       Date:  2008-10-25
View more
  5 in total

Review 1.  Interventions to enable communication for adult patients requiring an artificial airway with or without mechanical ventilator support.

Authors:  Louise Rose; Anna-Liisa Sutt; Andre Carlos Amaral; Dean A Fergusson; Orla M Smith; Craig M Dale
Journal:  Cochrane Database Syst Rev       Date:  2021-10-12

Review 2.  Laryngeal complications after tracheal intubation and tracheostomy.

Authors:  S Wallace; B A McGrath
Journal:  BJA Educ       Date:  2021-04-21

Review 3.  Management of tracheostomies in the intensive care unit: a scoping review.

Authors:  Kirsty A Whitmore; Shane C Townsend; Kevin B Laupland
Journal:  BMJ Open Respir Res       Date:  2020-07

4.  Above cuff vocalisation (ACV): A scoping review.

Authors:  Antonija Petosic; Marit F Viravong; Anna M Martin; Cecilie B Nilsen; Kjell Olafsen; Helene Berntzen
Journal:  Acta Anaesthesiol Scand       Date:  2020-11-01       Impact factor: 2.105

5.  Determining the Prevalence, Implementation Approaches, and Opinions of Above Cuff Vocalization: A Survey of Health Care Professionals.

Authors:  Claire S Mills; Emilia Michou; Mark C Bellamy; Heidi J Siddle; Cathy A Brennan; Chris Bojke
Journal:  Arch Phys Med Rehabil       Date:  2021-09-22       Impact factor: 3.966

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.